Member Info for solstace

Not sure! Abingdon is very interesting though and could produce the Sona test under license in the UK......

The Native Antigen Company is an Oxford-based contract service provider to the in vitro diagnostics industry.
Working with Sona, GE healthcare etc on a rapid Covid19 test + supplying global reagents for test and vaccine research

OXGENE™ accelerates therapy discovery and production, while improving accessibility to manufacturers and patients.
Collaborating with Native anigen company on reagent manufacturing

Sense bio detection is developing user-centred, handheld diagnostic test devices in the fields of infection and oncology.
Already working on their own Covid19 rapid test whith philips medi-size

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services.

Redex pharma One of the largest biotechnical companies in Europe, focused on addressing high unmet medical needs in cancer and infectious disease.

Celentyx is a human immune system focused R&D and service company.

Visit website

Also in the portfolio

Biofortuna A provider of molecular diagnostics which applies its freeze-drying expertise and proprietary cryo-preservatives to freeze-dry and stabilise all reagents required for PCR including Taq polymerase.

Also in the portfolio

Abingdon Health is a lateral flow diagnostic testing specialist, undertaking research and development of new testing products and following successful genesis of new testing devices, is able to manufacture products in high volumes.

https://www.newsfilecorp.com/release/52396/Sona-announces-key-partner-for-Coronavirus-Rapid-Screening-Test

If awareness of Merc and its 4 portfolio companies involvement in Covid19 testing and vaccine R&D hits the levels of NCYT mania then this will KaaaaaaBoooooM

How many tests can 500nu supply...... Bet it aint that many.....1000 maybe 10,000

Exactly buddy, just need to clarify who's got what stake in this? Ive contacted Merc, native antigen and Sona all being tight lipped. Time will tell :-)

Being fast tracked by Sona nanotech, native antigen company UK (merc 30.6%) and GE healthcare (multi billion dollar company) also has full data and analytic tracking for monitoring Covid19 transmission rates and pattern of spread from Bond digital health a UK company. Only rapid test under development due to launch soon that is fully trackable allowing Govts to track spread! Its the test all Govts are looking for!

https://www.taiwannews.com.tw/en/news/3911659

https://twitter.com/Soulbythewater/status/1247286963792687104?s=19

https://www.technologynetworks.com/diagnostics/blog/developing-antibodies-and-antigens-for-covid-19-diagnostics-333088

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager, today announces that two of its direct portfolio companies, The Native Antigen Company Limited ("NAC") and Oxford Genetics Limited (trading as "OXGENE") have formed a new strategic partnership to scale up COVID-19 antigen production.

Current COVID-19 tests use the polymerase chain reaction that detects the virus's genome. Although an important first step, these tests can only detect ongoing COVID-19 infections. NAC's antigens, already supplied on a global basis, can be used to develop smaller, point-of-care antibody test kits that could also be used on a mass basis at the community level for the confirmation of historic COVID-19 infection and provide research agents for the development of vaccine candidates. This partnership will see both companies working together towards developing more scalable technologies for cost-effective infectious disease reagent production.

Mm's lol

https://businessnewswales.com/medtech-sector-proves-its-worth-in-coronavirus-pandemic/